首页> 外文期刊>Scandinavian journal of immunology. >Effects of cytokines, butyrate and dexamethasone on serum amyloid A and apolipoprotein A-I synthesis in human HUH-7 hepatoma cells.
【24h】

Effects of cytokines, butyrate and dexamethasone on serum amyloid A and apolipoprotein A-I synthesis in human HUH-7 hepatoma cells.

机译:细胞因子,丁酸酯和地塞米松对人HUH-7肝癌细胞中血清淀粉样蛋白A和载脂蛋白A-1合成的影响。

获取原文
获取原文并翻译 | 示例
           

摘要

Serum amyloid A (SAA) and apolipoprotein A-I (apo A-I) are secreted by the liver. As concentrations of both apolipoproteins are inversely related under normal and acute-phase conditions, human HUH-7 hepatoma cells were stimulated with interleukin (IL)-1alpha (100 and 200 U), IL-6 (50 and 100 U), butyrate (2 mM) and dexamethasone (2 x 10(-7)M and 1 x 10(-6)M), alone or in combination. Changes in SAA and apo A-I synthesis were monitored after metabolic labelling of the cells with [35S]-methionine. Intracellular and secreted SAA and apo A-I were immunoprecipitated, separated by sodium dodecyl sulphate-polyacrylamide gel electrophoresis (SDS-PAGE), and the radioactivity in the corresponding bands was counted. Intracellular apolipoprotein levels were increased by all stimuli, either alone or in combination, between 2.7- and 5.5-fold (SAA) and between 2.8- and 4.1-fold (apo A-I), respectively. In a similar manner, apolipoprotein levels secreted by HUH-7 cells were increased between 3.1- and 4.3-fold (SAA) and between 1.9- and 3. 3-fold (apo A-I). Co-administration of cytokines, butyrate and/or dexamethasone had no pronounced synergistic effect on intracellular biosynthesis and secretion of SAA and apo A-I. The results from the present study suggest that apo A-I must not necessarily be considered as a negative acute-phase reactant.
机译:肝脏分泌血清淀粉样蛋白A(SAA)和载脂蛋白A-1(apo A-1)。由于两种载脂蛋白的浓度在正常和急性期条件下均呈负相关,因此人白细胞介素(IL)-1alpha(100和200 U),IL-6(50和100 U),丁酸盐( 2 mM)和地塞米松(2 x 10(-7)M和1 x 10(-6)M),单独使用或组合使用。用[35S]-蛋氨酸对细胞进行代谢标记后,监测SAA和apo A-I合成的变化。免疫沉淀细胞内和分泌的SAA和apo A-I,通过十二烷基硫酸钠-聚丙烯酰胺凝胶电泳(SDS-PAGE)分离,并计数相应谱带中的放射性。通过单独或组合的所有刺激,细胞内载脂蛋白水平分别增加了2.7至5.5倍(SAA)和2.8至4.1倍(Apo A-1)。以类似的方式,HUH-7细胞分泌的载脂蛋白水平在3.1至4.3倍(SAA)和1.9至3. 3倍之间(apo A-1)升高。细胞因子,丁酸酯和/或地塞米松的共同给药对细胞内生物合成以及SAA和apo A-I的分泌没有明显的协同作用。本研究的结果表明,载脂蛋白A-I不一定必须被视为负急性期反应物。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号